NeoGenomics Reports Fourth Quarter and Full Year 2023 Results
Fourth Quarter Revenue Increased 12% to $156 million; Full Year Revenue Increased 16% to $592 million ...
Stay updated with breaking news from Adjusted Diluted. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fourth Quarter Revenue Increased 12% to $156 million; Full Year Revenue Increased 16% to $592 million ...
NeoGenomics, Inc. (the "Company"), a leading provider of oncology testing and global contract research services, today announced fourth quarter and full year 2023 results for the period ended December 31, 2023. Highlights Fourth quarter...
Strong Earnings and Margin Expansion Underpinned by Uniquely Positioned Aggregates Business Fourth Quarter Earnings per Share Increased 89% and Gross Profit Margin Expanded 550 bps Earnings Growth...
Net Sales Decline While Adjusted EBITDA Reaches Record High
Article - Wyndham Hotels & Resorts Reports Fourth Quarter 2023 Results - System-wide rooms grew organically by 3.5% year-over-year, a record high. Development pipeline grew 1% sequentially and by 10% year-over-year to a record 240,000 rooms.